Physicians' Academy for Cardiovascular Education

Efficacy and safety of P2Y12 inhibitors comparable between men and women

Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials

Literature - Lau ES, Braunwald E, Murphy SA, et al. - J Am Coll Cardiol. 2017;69(12):1549-1559

Main results


The efficacy and safety of P2Y12 inhibitors is comparable between women and men. These findings support the use of these therapies in both genders with appropriate indications for use.


Show references

Find this article online at JACC

Share this page with your colleagues and friends: